Calcineurin
10 drugs ImmunologyOphthalmology
1
approved indications
10
Approved Drugs
9
Companies
5
Indications
2
Therapeutic Areas
Top Drugs
Unlock Full Target Intelligence PRO
✓ Competitive landscape by company (9 companies)
✓ All 10 approved drugs
✓ Therapeutic area breakdown
✓ Full indication list (5 indications)
✓ Patent cliff analysis
✓ Clinical trials pipeline
Upgrade to Pro
Starting at $99/mo
Drugs by Company
ASTELLAS 2 drugs
Sun Pharma 1 drug
VELOXIS PHARMS INC 1 drug
By Therapeutic Area
Other 7 drugs
Immunology 2 drugs
Drugs by Company PRO
ASTELLAS 2 drugs
Sun Pharma 1 drug
VELOXIS PHARMS INC 1 drug
Teva 1 drug
BAUSCH 1 drug
LEO PHARMA AS 1 drug
AURINIA 1 drug
HARROW EYE 1 drug
ACCORD HLTHCARE 1 drug
By Therapeutic Area
Other 7 drugs
ASTAGRAF XL, PROGRAF, CEQUA, ENVARSUS XR +3 more
Immunology 2 drugs
PIMECROLIMUS, ELIDEL
Ophthalmology 1 drugs
VEVYE
Indications Treated
Organ RejectionKeratoconjunctivitis SiccaAtopic DermatitisLupus NephritisDry Eye Disease
All Drugs Targeting Calcineurin
| Drug | Company | Approved | Indications | Therapeutic Area |
|---|---|---|---|---|
| ASTAGRAF XL | ASTELLAS | 2013 | 1 | |
| PROGRAF | ASTELLAS | 1994 | 1 | |
| CEQUA | Sun Pharma | 2018 | 1 | |
| ENVARSUS XR | VELOXIS PHARMS INC | 2015 | 1 | |
| PIMECROLIMUS | Teva | 2018 | 1 | Immunology |
| ELIDEL | BAUSCH | 2001 | 1 | Immunology |
| PROTOPIC | LEO PHARMA AS | 2000 | 1 | |
| LUPKYNIS | AURINIA | 2021 | 1 | |
| VEVYE | HARROW EYE | 2023 | 1 | Ophthalmology |
| TACROLIMUS | ACCORD HLTHCARE | 2009 | - |